Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Uramoto

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Bioscience, Biotechnology, and Biochemistry|August 1, 1995
1'-Acetoxychavicol acetate as an inhibitor of phagocytosis of macrophagesN Watanabe, T Kataoka, T Tajika, et al.
The Journal of Antibiotics|May 29, 1999
New types of liposidomycins produced by Streptomyces that inhibit bacterial peptidoglycan synthesis. Structure elucidation of fatty acid components by tandem mass spectrometryY Esumi, Y Suzuki, K Kimura, et al.
FEBS Letters|March 21, 1983
Specific binding of chartreusin, an antitumor antibiotic, to DNAM Uramoto, T Kusano, T Nishio, et al.
The Journal of Antibiotics|May 1, 1997
Propeptin, a new inhibitor of prolyl endopeptidase produced by Microbispora. I. Fermentation, isolation and biological propertiesK Kimura, F Kanou, H Takahashi, et al.
Bioscience, Biotechnology, and Biochemistry|June 1, 1997
Novel amino acid metabolite produced by Streptomyces sp.: I. Taxonomy, isolation, and structural elucidationT Tajika, I Bando, T Furuta, et al.
The Journal of Antibiotics|December 1, 1988
A new antifungal antibiotic, cystargin: fermentation, isolation, and characterizationM Uramoto, Y Itoh, R Sekiguchi, et al.
Bioscience, Biotechnology, and Biochemistry|January 1, 1994
Screening for specific inhibitors of phagocytosis of thioglycollate-elicited macrophagesJ Magae, T Nagi, K Takaku, et al.
The Journal of Rheumatology|May 17, 2000
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991M Shbeeb, K M Uramoto, L E Gibson, et al.
Immunopharmacology|February 1, 1995
Anti-inflammatory effects and specificity of L-156,602: comparison of effects on concanavalin A and zymosan-induced footpad edema, and contact sensitivity responseR F Tsuji, J Yamakoshi, M Uramoto, et al.
Bioscience, Biotechnology, and Biochemistry|October 1, 1992
Preferential suppression of delayed-type hypersensitivity by L-156,602, a C5a receptor antagonistR F Tsuji, M Uramoto, H Koshino, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Bioscience, Biotechnology, and Biochemistry|August 1, 1995
1'-Acetoxychavicol acetate as an inhibitor of phagocytosis of macrophagesN Watanabe, T Kataoka, T Tajika, et al.
The Journal of Antibiotics|May 29, 1999
New types of liposidomycins produced by Streptomyces that inhibit bacterial peptidoglycan synthesis. Structure elucidation of fatty acid components by tandem mass spectrometryY Esumi, Y Suzuki, K Kimura, et al.
FEBS Letters|March 21, 1983
Specific binding of chartreusin, an antitumor antibiotic, to DNAM Uramoto, T Kusano, T Nishio, et al.
The Journal of Antibiotics|May 1, 1997
Propeptin, a new inhibitor of prolyl endopeptidase produced by Microbispora. I. Fermentation, isolation and biological propertiesK Kimura, F Kanou, H Takahashi, et al.
Bioscience, Biotechnology, and Biochemistry|June 1, 1997
Novel amino acid metabolite produced by Streptomyces sp.: I. Taxonomy, isolation, and structural elucidationT Tajika, I Bando, T Furuta, et al.
The Journal of Antibiotics|December 1, 1988
A new antifungal antibiotic, cystargin: fermentation, isolation, and characterizationM Uramoto, Y Itoh, R Sekiguchi, et al.
Bioscience, Biotechnology, and Biochemistry|January 1, 1994
Screening for specific inhibitors of phagocytosis of thioglycollate-elicited macrophagesJ Magae, T Nagi, K Takaku, et al.
The Journal of Rheumatology|May 17, 2000
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991M Shbeeb, K M Uramoto, L E Gibson, et al.
Immunopharmacology|February 1, 1995
Anti-inflammatory effects and specificity of L-156,602: comparison of effects on concanavalin A and zymosan-induced footpad edema, and contact sensitivity responseR F Tsuji, J Yamakoshi, M Uramoto, et al.
Bioscience, Biotechnology, and Biochemistry|October 1, 1992
Preferential suppression of delayed-type hypersensitivity by L-156,602, a C5a receptor antagonistR F Tsuji, M Uramoto, H Koshino, et al.
Pageof 4